Establishment Labs (NASDAQ:ESTA) Shares Down 6% – Should You Sell?

Establishment Labs Holdings Inc. (NASDAQ:ESTA) fell 6% on Tuesday . The stock traded as low as $31.14 and last traded at $31.69. 738,442 shares traded hands during mid-day trading, a decline of 23% from the average session volume of 956,751 shares. The stock had previously closed at $33.71.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on ESTA. Stephens upgraded shares of Establishment Labs to a “strong-buy” rating in a report on Monday, December 2nd. Citigroup upped their target price on shares of Establishment Labs from $45.00 to $50.00 and gave the company a “neutral” rating in a research note on Tuesday, October 1st. Finally, BTIG Research upped their target price on shares of Establishment Labs from $62.00 to $65.00 and gave the company a “buy” rating in a research note on Monday, October 14th. One investment analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $60.60.

Establishment Labs Price Performance

The company’s 50-day moving average price is $44.04 and its 200-day moving average price is $43.68. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29. The company has a market cap of $922.81 million, a P/E ratio of -12.78 and a beta of 1.15.

Institutional Investors Weigh In On Establishment Labs

Several large investors have recently made changes to their positions in the stock. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in Establishment Labs by 1.8% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 35,236 shares of the company’s stock worth $1,525,000 after purchasing an additional 632 shares during the last quarter. Hood River Capital Management LLC acquired a new position in Establishment Labs during the second quarter worth $43,000. Verition Fund Management LLC boosted its holdings in Establishment Labs by 22.8% during the third quarter. Verition Fund Management LLC now owns 9,400 shares of the company’s stock worth $407,000 after purchasing an additional 1,746 shares during the last quarter. HighTower Advisors LLC boosted its holdings in Establishment Labs by 32.5% during the third quarter. HighTower Advisors LLC now owns 10,311 shares of the company’s stock worth $446,000 after purchasing an additional 2,529 shares during the last quarter. Finally, SkyView Investment Advisors LLC boosted its holdings in Establishment Labs by 30.5% during the third quarter. SkyView Investment Advisors LLC now owns 12,000 shares of the company’s stock worth $519,000 after purchasing an additional 2,805 shares during the last quarter. Institutional investors own 72.91% of the company’s stock.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.